Future cancer research priorities in the USA: a Lancet Oncology Commission.
about
Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine.Mechanotransduction in tumor progression: The dark side of the force.Antimetabolic Effects of Polyphenols in Breast Cancer Cells: Focus on Glucose Uptake and Metabolism.Mediterranean Diet and Breast Cancer Risk.Epidemiological science and cancer control
P2860
Future cancer research priorities in the USA: a Lancet Oncology Commission.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Future cancer research priorities in the USA: a Lancet Oncology Commission.
@en
Future cancer research priorities in the USA: a Lancet Oncology Commission.
@nl
type
label
Future cancer research priorities in the USA: a Lancet Oncology Commission.
@en
Future cancer research priorities in the USA: a Lancet Oncology Commission.
@nl
prefLabel
Future cancer research priorities in the USA: a Lancet Oncology Commission.
@en
Future cancer research priorities in the USA: a Lancet Oncology Commission.
@nl
P2093
P50
P1433
P1476
Future cancer research priorities in the USA: a Lancet Oncology Commission.
@en
P2093
A Lindsay Frazier
Alan Ashworth
Alfred Yung
Andrew Futreal
Anna D Barker
Atul J Butte
Beverly Mitchell
Brian Kavanagh
Brian M Alexander
Chanita Hughes-Halbert
P304
P356
10.1016/S1470-2045(17)30698-8
P577
2017-10-31T00:00:00Z